COVID-19: Multisystem Inflammatory Syndrome

Although children rarely develop severe COVID-19 symptoms, a number of pediatric cases have been reported that associate SARS-CoV-2 infection with the development of a proinflammatory syndrome resembling Kawasaki disease and toxic shock syndrome. Ongoing research into this Multisystem Inflammatory Syndrome (MIS-C) is highlighted in this feed.

September 17, 2021
Open Access

Comparison of children and young people admitted with SARS-CoV-2 across the UK in the first and second pandemic waves: prospective multicentre observational cohort study

MedRxiv : the Preprint Server for Health Sciences
S. V. Swann ISARIC4C Investigators
September 17, 2021

Coagulation profiles and viscoelastic testing in multisystem inflammatory syndrome in children.

Pediatric Blood & Cancer
Ashish A AnkolaChristina J VanderPluym
September 17, 2021
Open Access

Host Genetics and Antiviral Immune Responses in Adult Patients With Multisystem Inflammatory Syndrome.

Frontiers in Immunology
Andreas RonitTrine H Mogensen
September 17, 2021

Association of Blood Groups with the Severity and Outcome of COVID-19 Infection in Children.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
Attia BariMasood Sadiq
September 17, 2021

A case of papilledema associated with COVID-19 multisystem inflammatory syndrome in children.

Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie
Jennifer E ChungMargaret M Reynolds
September 16, 2021
Case Report

Urticarial Vasculitis: A Potential Signpost for Multisystem Inflammatory Syndrome in Children.

Journal of Cutaneous Pathology
Hailey L Gosnell, Douglas J Grider
September 16, 2021
Case Report

A case of post COVID-19 multisystem inflammatory syndrome and Bell's palsy in a young adult.

Clinical Case Reports
Abdulrahman F Al-Mashdali, Musaed S Al Samawi
September 16, 2021
Case Report

Croup and COVID-19 in a child: a case report and literature review.

BMJ Case Reports
Chee Chean LimJeyanthi Kulasegarah
September 14, 2021

A case of multisystem inflammatory syndrome (MIS-A) in an adult woman 18 days after COVID-19 vaccination.

Acta Clinica Belgica
Sofie StappersAnke Verlinden
September 13, 2021
Case Report

ST-elevation in an adolescent with COVID-19: Myopericarditis or myocardial infarction?

The American Journal of Emergency Medicine
Cathie-Kim LeAndrea T Vo
September 12, 2021
Open Access

Autoantibodies against IL-1-receptor-antagonist in multisystem inflammatory syndrome in children

MedRxiv : the Preprint Server for Health Sciences
J. PfeiferLorenz Thurner
September 11, 2021
Open Access

Kawasaki Disease- Management Strategies Given Symptoms Overlap to COVID-19: A Review.

JNMA; Journal of the Nepal Medical Association
Linna WangFuyong Jiao

Sign up to follow this feed and discover related papers.

Related Feeds

AI-driven COVID-19 Management

Artificial intelligence (AI) offers a powerful new tool that could potentially be instrumental in controling and managing the SARS-CoV-2 virus. The papers in this feed report on the applications of AI to the current pandemic, which may be able to predict the location of the next outbreak, or facilitate new drug design.


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

COVID-19 Cardiovascular Complications

Growing evidence shows that COVID-19 can result in serious complications affecting the cardiovascular system, including dysrhythmias, myocarditis, acute myocardial infarction, and heart failure. This feed follows studies investigating the effects of SARS-CoV-2 infection on the heart.

COVID-19 Clinical Diagnosis

COVID-19 patients typically present with high fever and a persistent cough. This feed focuses on clinical diagnosis, including RT-PCR testing for the presence of SARS-CoV-2 and radiographic assessment of lungs.

COVID-19 Clinical Management

While most COVID-19 infections cause only mild to moderate symptoms, severely affected patients, such as those presenting with pneumonia, ARDS or septic shock, require hospitalization. This feed focuses on clinical management of patients using oxygen therapy, ventilation, and other treatment strategies, and covers some medical case reports.

COVID-19 Comorbidities

COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes, hypertension, cardiovascular disease, and chronic lung disease. Research into the intersection between comorbidities and COVID-19 is focusing on risks and treatment outcomes for these patients.

COVID-19 Complications

A growing number of complications associated with COVID-19 has been identified. This feed focuses primarily on cardiovascular and respiratory manifestations in severely ill patients.

COVID-19 Covalescent Plasma Therapy

Convalescent plasma therapy, where passive polyclonal antibody obtained from recovered patients are used to provide immediate immunity, has been tested in respiratory infections such as the 2009-2010 H1N1 influenza virus pandemic and the 2003 SARS-CoV-1 epidemic. This feed follows ongoing research efforts and clinical trials exploring covalescent plasma therapy as a potential treatment strategy for COVID-19.

COVID-19 Epidemiology and Demography

Epidemiological studies play a crucial role in understanding and managing the progression of COVID-19. Research followed in this feed includes studies of transmission dynamics and the change of the basic reproductive number (R) as new pubic health measures take effect.

COVID-19 Immune Response

Understanding the innate and acquired immune response to SARS-CoV-2 is essential for development of COVID-19 therapeutic treatment and design of prophylactic vaccines. This feed surfaces immunological studies, including studies into the cytokine storm that has been observed in severely ill patients.

© 2021 Meta ULC. All rights reserved